NewcelX Ltd.
NCELNasdaqHealthcare · Pharmaceutical Preparations · V8 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 20-Fmissed a reporting deadline ↗May 1, 2025
- NT 20-Fmissed a reporting deadline ↗Apr 30, 2024
- NT 20-Fmissed a reporting deadline ↗May 1, 2023
- NT 20-Fmissed a reporting deadline ↗Apr 30, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- League Jinn SarlActivist (13D)May 4, 2026
- Revel MichelActivist (13D)Nov 14, 2025
- Twito RonenActivist (13D)Nov 13, 2025
- Clover Wolf Capital - Limited PartnershipPassive (13G)Nov 7, 2025
- Biotechnology Value Fund L PPassive (13G)Nov 4, 2025
- Hafner RonaldActivist (13D)Jun 24, 2025
- Lind Global Fund Ii LpPassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Samuel OlivierDirector | Apr 27, 2026 | Buy | 81,818 | $2.75 |
| Revel MichelOfficer — CSO and Director | Apr 27, 2026 | Buy | 54,545 | $2.75 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 49,735 | 1.8 | -10.1% |
| Apr 30, 2026 | 55,338 | 1.0 | +13.0% |
| Apr 15, 2026 | 48,984 | 2.3 | +40.8% |
| Mar 31, 2026 | 34,791 | 2.3 | -3.4% |
| Mar 13, 2026 | 36,007 | 1.3 | -62.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 27, 2026
- EFFECTMay 15, 2026
- DMay 13, 2026
- F-3REGISTRATION STATEMENTMay 11, 2026
- EFFECTMay 6, 2026
- POS AMPOST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1May 5, 2026
- SCHEDULE 13DMay 4, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 30, 2026
- 20-FANNUAL REPORTApr 29, 2026
- 4Apr 29, 2026
- 4Apr 29, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 20, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 1, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.